Literature DB >> 6175566

Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection.

K Kato, K Yamamoto.   

Abstract

Previous intravenous (i.v.) injection of heat-killed Bacillus Calmette-Guérin (BCG) in mice produced a suppression of delayed-type hypersensitivity (DTH) induced with oil-treated BCG cell walls. This phenomenon was analysed by the macrophage migration inhibition (MI) test in which non-adherent spleen cells from mice which had been injected with heat-killed BCG (K-Non-ad. cells) were mixed with peritoneal exudate cells from BCG cell wall-immunized mice (effector-PEC). The test showed that the K-Non-ad. cells suppressed the MI activity in the effector-PEC, which indicated that the suppressor cells were induced in the spleen by the heat-killed BCG injections. Moreover, the suppressive effect of the K-Non-ad. cells disappeared after treatment with anti-brain associated theta serum (BA theta) and guinea-pig complement, and operated across the H-2 barrier. The suppressor cells inhibited the production or release of the migration inhibition factor from the BCG cell wall-sensitized cells in the presence of the specific antigen, purified protein derivatives (PPD). It was concluded that the injections of heat-killed BCG produced antigen non-specific suppressor T cells in DTH suppression.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175566      PMCID: PMC1555398     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Studies on the role of suppressor cells in specific unresponsiveness to DNCB.

Authors:  L Polak
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

2.  A splenic requirement for the generation of suppressor T cells.

Authors:  M S Sy; S D Miller; H B Kowach; H N Claman
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

3.  BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro.

Authors:  G R Klimpel; C S Henney
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

4.  [Splenic suppressor cells and cell-mediated cytotoxicity in murine schistosomiasis].

Authors:  P A Coulis; R M Lewert; F W Fitch
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

5.  Tolerance and contact sensitivity to DNFB in mice. 3. Transfer of tolerance with "suppressor T cells".

Authors:  P Phanupak; J W Moorhead; H N Claman
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

6.  Depression of the T cell phenomenon of contact sensitivity by T cells from unresponsive mice.

Authors:  M Zembala; G L Asherson
Journal:  Nature       Date:  1973-07-27       Impact factor: 49.962

7.  Biological effects of the adjuvant Corynebacterium parvum. II. Evidence for macrophage-T-cell interaction.

Authors:  M T Scott
Journal:  Cell Immunol       Date:  1972-11       Impact factor: 4.868

8.  Role of the thymus in tolerance. X. "Suppressor" activity of antigen-stimulated rat thymocytes transferred to normal recipients.

Authors:  T Y Ha; B H Waksman
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

9.  Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum.

Authors:  H Kirchner; H T Holden
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

10.  Immunogenicity of cell walls from various mycobacteria against airborne tuberculosis in mice.

Authors:  W Brehmer; R L Anacker; E Ribi
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

View more
  9 in total

1.  Difference in the induction of macrophage interleukin-1 production between viable and killed cells of Listeria monocytogenes.

Authors:  M Mitsuyama; K Igarashi; I Kawamura; T Ohmori; K Nomoto
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

2.  Induction by an immunogenic immunomodulating agent of nonspecific T cell suppression of lymphocyte responsiveness in MLR but not of antibody production.

Authors:  C Reuben; D Halperin; S Ben-Efraim; D W Weiss
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 3.  Genetic aspects of innate resistance and acquired immunity to mycobacteria in inbred mice.

Authors:  E Buschman; A S Apt; B V Nickonenko; A M Moroz; M H Averbakh; E Skamene
Journal:  Springer Semin Immunopathol       Date:  1988

4.  Influence of subclass-specific anti-idiotypic antibodies on the kinetics of the immune response to BCG.

Authors:  H Daus; H J Hammer; K Rajki; H Mauch
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

5.  Strain differences in lung granuloma formation in response to a BCG cell-wall vaccine in mice. Failure of antigen presentation by low-responder macrophages.

Authors:  M Kakinuma; K Onoé; R Yasumizu; K Yamamoto
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

6.  Depression of delayed-type hypersensitivity in mice with hypothalamic lesion induced by monosodium glutamate: involvement of neuroendocrine system in immunomodulation.

Authors:  K Kato; N Hamada; N Mizukoshi; K Yamamoto; T Kimura; C Ishihara; Y Fujioka; T Kato; K Fujieda; N Matsuura
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

7.  Effective Host-Directed Therapy for Tuberculosis by Depletion of Myeloid-Derived Suppressor Cells and Related Cells Using a Diphtheria Toxin Fusion Protein.

Authors:  Sadiya Parveen; Shichun Lun; Michael E Urbanowski; Mitchell Cardin; Jessica Shen; John R Murphy; William R Bishai
Journal:  J Infect Dis       Date:  2021-12-01       Impact factor: 5.226

8.  Suppressor T cells in BCG-treated mice interfere with an in vivo specific antitumoral immune response.

Authors:  B Payelle; M Brulay-Rosset; M F Poupon; G Lespinats
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

Review 9.  The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis.

Authors:  Tandeka Magcwebeba; Anca Dorhoi; Nelita du Plessis
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.